CXCL8 and idiopathic pulmonary fibrosis: Treatment with pirfenidone and nintedanib had modest effects on HBE cells of IPF patients as IL-6 and IL-8 production was mostly unaffected (Figure 6C,D), but treatment with saracatinib significantly reduced both IL-6 and IL-8 production (p = 0.02).